SNCA and Parkinson disease: These include direct effects of alpha-synuclein pathology, the hallmark protein aggregation in Parkinson's disease; secondary effects of neurodegeneration in connected gray matter regions; alterations in neurotransmitter systems, particularly the dopaminergic system; and potential contributions from vascular factors, which are increasingly recognized in Parkinson's disease pathology.